Accelerate Diagnostics Inc Sustainability Reports

Accelerate Diagnostics, Inc. focuses on developing and commercializing automated instrumentation systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. Its systems aim to improve patient outcomes and lower healthcare costs by providing faster diagnosis of serious infections such as sepsis.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 2549007HE5QY1QEQ8K43

FIGI: BBG001S6TPB4

8 reports from 2012 to 2023

• Accelerate Diagnostics Inc 2023 Annual Report
• Accelerate Diagnostics Inc 2022 Form 10-K
• Accelerate Diagnostics Inc 2020 Annual Report
• Accelerate Diagnostics Inc 2017 Form 10-K
• Accelerate Diagnostics Inc 2016 Form 10-K (Annual Report)